Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v2.4.0.8
Condensed Consolidated Statements of Operations (USD $)
3 Months Ended 9 Months Ended 75 Months Ended
Apr. 30, 2014
Apr. 30, 2013
Apr. 30, 2014
Apr. 30, 2013
Apr. 30, 2014
Expenses:          
Research and development $ 1,700,656 $ 707,660 $ 3,933,611 $ 2,362,872 $ 10,046,659
General and administrative 2,115,374 1,001,518 4,472,692 2,941,625 12,715,324
Loss from operations (3,816,030) (1,709,178) (8,406,303) (5,304,497) (22,761,983)
Other income (expense):          
Fair value of derivative liabilities in excess of proceeds         (808,590)
Adjustments to fair value of derivative liabilities         3,150,986
Loss on extinguishment of debt         (761,492)
Financing transaction costs         (210,000)
Non-cash interest expense   (19,481) (20,684) (71,075) (370,466)
Interest expense         (1,357)
Impairment charges         (9,000)
Net loss before income taxes (3,816,030) (1,728,659) (8,426,987) (5,375,572) (21,771,902)
Provision (benefit) for income taxes 814   41,773 2,000 47,773
Net loss $ (3,816,844) $ (1,728,659) $ (8,468,760) $ (5,377,572) $ (21,819,675)
Basic net loss per common share (in dollars per share) $ (0.02) $ (0.01) $ (0.05) $ (0.05)  
Diluted net loss per common share (in dollars per share) $ (0.02) $ (0.01) $ (0.05) $ (0.05)  
Weighted average shares used in computing basic net loss per common share (in shares) 207,288,109 117,859,000 175,782,229 102,717,806  
Weighted average shares used in computing diluted net loss per common share (in shares) 207,288,109 117,859,000 175,782,229 102,717,806